| Patents > Guidance, Tools, and Manuals > Classification > Class Schedule |
|
|
|
| Class Numbers & Titles | Class Numbers Only | USPC Index | International | HELP |
|
| You are viewing a USPC Schedule. |
|
| Class 435 | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY |
| Click here for a printable version of this file | |
![[List of Pre Grant Publications for class 435 subclass 1.1]](../as.gif) | ![[List of Patents for class 435 subclass 1.1]](../ps.gif) | 1.1 | DIFFERENTIATED TISSUE OR ORGAN OTHER THAN BLOOD, PER SE, OR DIFFERENTIATED TISSUE OR ORGAN MAINTAINING; COMPOSITION THEREFOR |
| | 2 | MAINTAINING BLOOD OR SPERM IN A PHYSIOLOGICALLY ACTIVE STATE OR COMPOSITIONS THEREOF OR THEREFOR OR METHODS OF IN VITRO BLOOD CELL SEPARATION OR TREATMENT |
| | 3 | CONDITION RESPONSIVE CONTROL PROCESS |
| | 4 | MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP |
| | 5 |  Involving virus or bacteriophage |
| | 6 | Involving nucleic acid |
| | 7.1 | Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay |
| | 7.2 |  Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate |
| | 7.21 |  Animal cell |
| | 7.22 |  Parasite or protozoa |
| | 7.23 | Tumor cell or cancer cell |
| | 7.24 | Leukocyte (e.g., lymphocyte, granulocyte, monocyte, etc.) |
| | 7.25 | Erythrocyte |
| | 7.3 | Flagellar-antigen or pili-antigen |
| | 7.31 | Fungi (e.g., yeast, mold, etc.) |
| | 7.32 | Bacteria or actinomycetales |
| | 7.4 | To identify an enzyme or isoenzyme |
| | 7.5 | Involving avidin-biotin binding |
| | 7.6 | Involving a modified enzyme (e.g., abzyme, recombinant, chemically altered, etc.) |
| | 7.7 | Assay in which a label present is an apoenzyme, prosthetic group, or enzyme cofactor |
| | 7.71 | Assay in which a label present is an enzyme inhibitor or functions to alter enzyme activity |
| | 7.72 | Assay in which a label present is an enzyme substrate or substrate analogue |
| | 7.8 | Involving nonmembrane bound receptor binding or protein binding other than antigen-antibody binding |
| | 7.9 | Assay in which an enzyme present is a label |
| | 8 | Involving luciferase |
| | 9 | Geomicrobiological testing (e.g., for petroleum, etc.) |
| | 10 | Involving uric acid |
| | 11 | Involving cholesterol |
| | 12 | Involving urea or urease |
| | 13 | Involving blood clotting factor (e.g., involving thrombin, thromboplastin, fibrinogen, etc.) |
| | 14 | Involving glucose or galactose |
| | 15 | Involving transferase |
| | 18 | Involving hydrolase |
| | 25 | Involving oxidoreductase |
| | 29 | Involving viable micro-organism |
| | 30 | Methods of sampling or inoculating or spreading a sample; methods of physically isolating an intact micro-organism |
| | 31 | Testing for sterility condition |
| | 32 | Testing for antimicrobial activity of a material |
| | 34 | Determining presence or kind of micro-organism; use of selective media |
| | 40.5 | Involving fixed or stabilized, nonliving microorganism, cell, or tissue (e.g., processes of staining, stabilizing, dehydrating, etc.; compositions used therefore, etc.) |
| | 41 | MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION |
| | 42 | Process involving micro-organisms of different genera in the same process, simultaneously |
| | 43 | Preparing compound having a 1-thia-4-aza-bicyclo (3.2.0) heptane ring system (e.g., penicillin, etc.) |
| | 44 | By desacylation of the substituent in 6-position |
| | 45 | By acylation of the substituent in 6-position |
| | 46 | In presence of phenyl acetic acid or phenyl acetamide or their derivatives |
| | 47 | Preparing compound having a 1-thia-5-aza-bicyclo (4.2.0) octane ring system (e.g., cephalosporin, etc.) |
| | 48 | Di-substituted in 7-position |
| | 49 | Cephalosporin C |
| | 50 | By acylation of the substituent in the 7-position |
| | 51 | By desacylation of the substituent in the 7-position |
| | 52 | Preparing compound containing a cyclopentanohydrophenanthrene nucleus; nor-, homo-, or D-ring lactone derivatives thereof |
| | 53 | Containing heterocyclic ring |
| | 54 | Acting on D-ring |
| | 58 | Hydroxylating |
| | 61 | Dehydrogenating; dehydroxylating |
| | 63 | Preparing compound containing a prostaglandin nucleus |
| | 64 | Preparing compound other than saccharide containing a tetracycline nucleus (e.g., naphacene, etc.) |
| | 65 | Preparing compound other than saccharide containing a gibberellin nucleus (i.e., gibbane) |
| | 66 | Preparing compound other than saccharide containing alloxazine or isoalloxazine nucleus |
| | 67 | Preparing compound containing a carotene nucleus (i.e., carotene) |
| | 68.1 | Enzymatic production of a protein or polypeptide (e.g., enzymatic hydrolysis, etc.) |
| | 69.1 | Recombinant DNA technique included in method of making a protein or polypeptide |
| | 69.2 | Enzyme inhibitors or activators |
| | 69.3 | Antigens |
| | 69.4 | Hormones and fragments thereof |
| | 69.5 | Lymphokines or monokines |
| | 69.6 | Blood proteins |
| | 69.7 | Fusion proteins or polypeptides |
| | 69.8 | Signal sequence (e.g., beta-galactosidase, etc.) |
| | 70.1 | Using tissue cell culture to make a protein or polypeptide |
| | 71.1 | Using a micro-organism to make a protein or polypeptide |
| | 72 | Preparing compound containing saccharide radical |
| | 73 | Preparing S-glycoside (e.g., lincomycin, etc.) |
| | 74 | Preparing O-glycoside (e.g., glucosides, etc.) |
| | 76 | The hetero ring has eight or more ring members and only oxygen as ring hetero atoms (e.g., erythromycin, spiramycin, nystatin, etc.) |
| | 77 | Oxygen atom of the saccharide radical is directly linked through only acyclic carbon atoms to a nonsaccharide heterocyclic ring (e.g., bleomycin, phleomycin, etc.) |
| | 78 | Oxygen atom of the saccharide radical is directly bonded to a condensed ring system having three or more carboxyclic rings (e.g., dauomycin, adriamycin, etc.) |
| | 79 | Oxygen atom of the saccharide radical is bonded to a cyclohexyl radical (e.g., kasugamycin, etc.) |
| | 80 | Cyclohexyl radical is substituted by two or more nitrogen atoms (e.g., destomycin, neamin, etc.) |
| | 84 | Preparing nitrogen-containing saccharide |
| | 85 | N-glycoside |
| | 86 | Cobalamin (i.e., vitamin B12, LLD factor) |
| | 87 | Nucleoside |
| | 88 |  Having a fused ring containing a six-membered ring having two N-atoms in the same ring (e.g., purine nucleosides, etc.) |
| | 89 | Nucleotide |
| | 90 | Dinucleotide (e.g., NAD, etc.) |
| | 91.1 | Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.) |
| | 91.2 |  Acellular exponential or geometric amplification (e.g., PCR, etc.) |
| | 91.3 | Polynucleotide contains only ribonucleotide monomers |
| | 91.4 | Modification or preparation of a recombinant DNA vector |
| | 91.41 |  By insertion or addition of one or more nucleotides |
| | 91.42 | Involving deletion of a nucleotide or nucleotides from a vector |
| | 91.5 | Acellular preparation of polynucleotide |
| | 92 | Having a fused ring containing a six-membered ring having two N-atoms in the same ring (e.g., purine based mononucleotides, etc.) |
| | 93 | Mashing or wort making |
| | 94 | Produced by the action of an isomerase (e.g., fructose by the action of xylose isomerase on glucose, etc.) |
| | 95 | Produced by the action of a beta-amylase (e.g., maltose by the action of beta-amylase on amylose, etc.) |
| | 96 | Produced by the action of an exo-1.4 alpha glucosidase (e.g., dextrose by the action of glucoamylase on starch, etc.) |
| | 97 | Produced by the action of a glycosyl transferase (e.g., alpha, beta, gamma-cyclodextrins by the action of glycosyl transferase on starch, etc.) |
| | 98 | Produced by the action of an alpha-1, 6-glucosidase (e.g., amylose debranched amylopectin by the action of pullulanase, etc.) |
| | 99 | Produced by the action of a carbohydrase (e.g., maltose by the action of alpha amylase on starch, etc.) |
| | 100 | Disaccharide |
| | 101 | Polysaccharide of more than five saccharide radicals attached to each other by glycosidic bonds |
| | 105 | Monosaccharide |
| | 106 | Preparing alpha or beta amino acid or substituted amino acid or salts thereof |
| | 107 | Proline; hydroxyproline; histidine |
| | 108 | Tryptophan; tyrosine; phenylalanine; 3,4 dihydroxyphenylalanine |
| | 109 | Aspartic acid (asparaginic acid); asparagine |
| | 110 | Glutamic acid; glutamine |
| | 111 | Utilizing biotin or its derivatives |
| | 112 | Utilizing surfactant fatty acids or fatty acid esters (i.e., having seven or more atoms) |
| | 113 | Methionine; cysteine; cystine |
| | 114 | Citrulline; arginine; ornithine |
| | 115 | Lysine; diaminopimelic acid; threonine; valine |
| | 116 | Alanine; leucine; isoleucine; serine; homoserine |
| | 117 | Preparing heterocyclic carbon compound having only O, N, S, Se, or Te as ring hetero atoms |
| | 118 | Containing two or more hetero rings |
| | 119 | Containing at least two hetero rings bridged or fused among themselves or bridged or fused with a common carbocyclic ring system, (e.g., rifamycin, etc.) |
| | 120 | Nitrogen or oxygen hetero atom and at least one other diverse hetero ring atom in the same ring |
| | 121 | Nitrogen as only ring hetero atom |
| | 123 | Oxygen as only ring hetero atom |
| | 127 | Preparing compound containing at least three carbocyclic rings |
| | 128 | Preparing nitrogen-containing organic compound |
| | 130 | Preparing sulfur-containing organic compound |
| | 131 | Preparing organic compound containing a metal or atom other than H, N, C, O, or halogen |
| | 132 | Preparing oxygen-containing organic compound |
| | 133 | Containing quinone nucleus (i.e., quinoid structure) |
| | 134 | Fat; fatty oil; ester-type wax; higher fatty acid (i.e., having at least seven carbon atoms in an unbroken chain bound to a carboxyl group); oxidized oil or fat |
| | 135 | Carboxylic acid ester |
| | 136 | Containing a carboxyl group |
| | 137 | Sugar acid having five or more carbon atoms (i.e., aldonic, keto-aldonic, or saccharic acid) |
| | 139 | Lactic acid |
| | 140 | Acetic acid |
| | 141 | Propionic or butyric acid |
| | 142 | Polycarboxylic acid |
| | 143 | Having keto group (e.g., alpha-ketoglutaric acid, etc.) |
| | 144 | Tricarboxylic acid (e.g., citric acid, etc.) |
| | 145 | Dicarboxylic acid having four or less carbon atoms (e.g., fumaric, maleic, etc.) |
| | 146 | Hydroxy carboxylic acid |
| | 147 | Containing carbonyl group |
| | 155 | Containing hydroxy group |
| | 166 | Preparing hydrocarbon |
| | 168 | Preparing element or inorganic compound except carbon dioxide |
| | 169 | Using actinomycetales |
| | 170 | Using bacteria |
| | 171 | Using fungi |
| | 440 | PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION |
| | 441 | Mutation employing a chemical mutagenic agent |
| | 442 | By replacement of standard nucleic acid base with base analog (e.g., 5-bromouracil, etc.) |
| | 443 | By use of intercalating agent (e.g., acridine orange, etc.) |
| | 444 | By use of alkylating agent (e.g., nitrosoguanidine, etc.) |
| | 445 | By use of oxidative deamination agent (e.g., nitrous acid, etc.) |
| | 446 | Mutation employing radiation or electricity |
| | 449 | Fusion of cells |
| | 450 | Employing electric current |
| | 451 | One of the fusing cells is a human antibody-producing cell |
| | 452 | One of the fusing cells is a mouse antibody-producing cell |
| | 453 | One of the fusing cells is a plant cell |
| | 454 | One of the fusing cells is a microorganism (e.g., prokaryote, fungus, etc.) |
| | 455 | Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within an animal cell |
| | 456 | The polynucleotide is encapsidated within a virus or viral coat |
| | 458 | The polynucleotide is coated with or encapsulated within a lipid containing material (e.g., liposome, etc.) |
| | 459 | Involving particle-mediated transfection (i.e., biolistic transfection) |
| | 460 | Involving laser treatment of the cell before or during transfection |
| | 461 | Involving electroporation |
| | 462 | Involving site-specific recombination (e.g., Cre-lox, etc.) |
| | 463 | Involving general or homologous recombination (e.g., gene targeting, etc.) |
| | 464 | Involving gene duplication within the cell (e.g., amplification, co-amplification, etc.) |
| | 465 | Involving co-transfection |
| | 466 | The polynucleotide is a shuttle vector or a transiently replicating hybrid vector |
| | 467 | Introducing an oncogene to establish a cell line |
| | 468 | Introduction of a polynucleotide molecule into or rearrangement of a nucleic acid within a plant cell |
| | 469 | Introduction via Agrobacterium |
| | 470 | Introduction via electroporation, particle, fiber or microprojectile mediated insertion, or injection |
| | 471 | Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within a microorganism (e.g., bacteria, protozoa, bacteriophage, etc.) |
| | 472 | The polynucleotide is encapsidated within a bacteriophage, bacteriophage coat, or transducing particle |
| | 473 | The polynucleotide contains a transposon |
| | 474 | The polynucleotide is a cosmid |
| | 475 | The polynucleotide is unencapsidated bacteriophage or viral nucleic acid |
| | 476 | The polynucleotide is a plasmid or episome |
| | 477 | Plasmid or episome contains DNA targeting homologous recombination to bacteriophage, viral, or chromosomal DNA within a microorganism |
| | 478 | Plasmid or episome contains at least part of a gene encoding a restriction endonuclease or modification enzyme |
| | 479 | Plasmid or episome confers the ability to utilize directly a compound which a wild type microorganism is unable to utilize |
| | 480 | Plasmid or episome contains at least part of a gene encoding a toxin or encoding for virulence or pathogenicity |
| | 481 | Plasmid or episome contains a gene which complements a nutritional deficiency mutation |
| | 482 | Plasmid or episome contains a gene which confers resistance to metal, silicon, selenium, or tellurium toxicity |
| | 483 | Yeast is a host for the plasmid or episome |
| | 484 | Mycelial fungus is a host for the plasmid or episome |
| | 485 | Microorganism of the genus Bacillus is a host for the plasmid or episome |
| | 486 | Microorganism of the genus Streptomyces is a host for the plasmid or episome |
| | 487 | Microorganism of the genus Brevibacterium or the genus Corynebacterium is a host for the plasmid or episome |
| | 488 | Microorganism of the genus Escherichia is a host for the plasmid or episome |
| | 489 | Plural nonidentical plasmids are introduced into a host microorganism or culture thereof (e.g., plasmid is part of a library, etc.) |
| | 490 | The polynucleotide is an unbranched linear fragment |
| | 173.1 | TREATMENT OF MICRO-ORGANISMS OR ENZYMES WITH ELECTRICAL OR WAVE ENERGY (E.G., MAGNETISM, SONIC WAVES, ETC.) |
| | 173.2 | Enzyme treated |
| | 173.3 | Modification of viruses (e.g., attenuation, etc.) |
| | 173.4 | Cell membrane or cell surface is target |
| | 173.5 | Membrane permeability increased |
| | 173.7 | Lytic effect produced (e.g., disruption of cell membrane for release of subcellular parts; e.g., nucleic acids, etc.) |
| | 173.8 | Metabolism of micro-organism enhanced (e.g., growth enhancement or increased production of microbial product) |
| | 173.9 | Concentration, separation, or purification of micro-organisms |
| | 174 | CARRIER-BOUND OR IMMOBILIZED ENZYME OR MICROBIAL CELL; CARRIER-BOUND OR IMMOBILIZED CELL; PREPARATION THEREOF |
| | 175 | Multi-enzyme system |
| | 176 | Enzyme or microbial cell is immobilized on or in an inorganic carrier |
| | 177 | Enzyme or microbial cell is immobilized on or in an organic carrier |
| | 183 | ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES |
| | 184 | Enzyme inactivation by chemical treatment |
| | 185 | Malt |
| | 186 | Pancreatin |
| | 187 | Preparing granular- or free-flowing enzyme composition |
| | 188 | Stablizing an enzyme by forming a mixture, an adduct or a composition, or formation of an adduct or enzyme conjugate |
| | 188.5 | Catalytic antibody |
| | 189 | Oxidoreductase (1. ) (e.g., luciferase) |
| | 190 | Acting on CHOH group as donor (e.g., glucose oxidase, lactate dehydrogenase (1.1)) |
| | 191 | Acting on nitrogen-containing compound as donor (1.2, 1.5, 1.7) |
| | 192 | Acting on hydrogen peroxide as acceptor (1.11) |
| | 193 | Transferase other than ribonuclease (2.) |
| | 195 | Hydrolase (3. ) |
| | 196 | Acting on ester bond (3.1) |
| | 200 | Acting on glycosyl compound (3.2) |
| | 201 | Acting on alpha-1, 4-glucosidic bond, (e.g., hyaluronidase, invertase, amylase, etc. (some 3.2.1)) |
| | 202 | Alpha-amylase, microbial source |
| | 204 | Alpha-amylase, plant source (3.2.1.1) |
| | 205 | Glucoamylase (3.2.1.3) |
| | 206 | Acting on beta-1, 4 link between N-acetylmuramic acid and 2-acetylamino 2 deoxy-D-glucose (e.g., lysozyme, etc.) |
| | 207 | Acting on beta-galatose-glycoside bond (e.g., beta-galactosidase, etc.) |
| | 208 | Acting on alpha-galatose-glycoside bond (e.g., alpha-galactosidase, etc.) |
| | 209 | Acting on beta-1, 4-glucosidic bond (e.g., cellulase, etc. (3.2.1.4)) |
| | 210 | Acting on alpha-1, 6-glucosidic bond (e.g., isoamylase, pullulanase, etc.) |
| | 212 | Acting on peptide bond (e.g., thromboplastin, leucine amino-peptidase, etc., (3.4)) |
| | 213 | Trypsin; chymotrypsin |
| | 214 | Thrombin |
| | 215 | Urokinase |
| | 216 | Streptokinase |
| | 217 | Plasmin (i.e., fibrinolysin) |
| | 218 | Elastase |
| | 219 | Proteinase |
| | 227 | Acting on carbon to nitrogen bond other than peptide bond (3.5) |
| | 232 | Lyase (4. ) |
| | 233 | Isomerase (5. ) |
| | 235.1 | VIRUS OR BACTERIOPHAGE, EXCEPT FOR VIRAL VECTOR OR BACTERIOPHAGE VECTOR; COMPOSITION THEREOF; PREPARATION OR PURIFICATION THEREOF; PRODUCTION OF VIRAL SUBUNITS; MEDIA FOR PROPAGATING |
| | 325 | ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE |
| | 326 | Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof |
| | 327 | Immunoglobulin or antibody is anti-idiotypic |
| | 328 | Immunoglobulin or antibody is chimeric, mutated, or a recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobuin fusion protein, etc.) |
| | 329 | Immunoglobulin or antibody binds an oligosaccharide structure other than nucleic acid |
| | 330 | Immunoglobulin or antibody binds an expression product of a cancer related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.) |
| | 331 | Immunoglobulin or antibody binds a specifically identified amino acid sequence |
| | 332 | Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.) |
| | 333 | Binds a nucleic acid or derivative or component thereof (e.g., DNA, RNA, DNA-RNA, hybrid, nucleotide, nucleoside, carcinogen-DNA adduct, etc.) |
| | 334 | Binds a receptor (e.g., transferrin receptor, Fc receptor, dihydropyridine receptor, IL-2 receptor, etc.) |
| | 337 | Binds a plasma protein, serum protein, or fibrin (e.g., clotting factor fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.) |
| | 338 | Binds an enzyme |
| | 339 | Binds a virus or component or product thereof (e.g., virus associated antigen, etc.) |
| | 340 | Binds a bacterium or similar microorganism or component or product thereof (e.g., Streptococcus, Legionella, Mycoplasma, bacterium associated antigen, exotoxin, etc.) |
| | 341 | Binds a fungus or plant cell or component or product thereof (e.g., fungus associated antigen, etc.) |
| | 342 | Binds a parasitic protozoan or metazoan cell or component or product thereof; (e.g., Dirofilaria, Eimeria, Coccidia, Trichinella, parasite cell surface antigen, etc.) |
| | 344 | Binds a cancer cell or component or product thereof (e.g., cell surface antigen, etc.) |
| | 345 | Immunoglobulin or antibody binds a drug, hapten, hapten-carrier complex, or specifically identified chemical structure (e.g., theophylline, digoxin, etc.) |
| | 346 | Fused or hybrid cell, per se |
| | 347 | Two or more cell types, per se, in co-culture |
| | 348 | Insect cell, per se |
| | 349 | Avian cell, per se |
| | 350 | Canine cell, per se |
| | 351 | Feline cell, per se |
| | 352 | Rodent cell, per se |
| | 353 | Rat (i.e., Rattus) |
| | 354 | Mouse (i.e., Mus) |
| | 355 | Blood or lymphatic origin or derivative |
| | 356 | L cell or derivative (e.g., Ltk(-), etc.) |
| | 357 | Fibroblast, fibroblast-like cell or derivative (e.g., NIH 3T3, etc.) |
| | 358 | Chinese hamster ovary (i.e., CHO) |
| | 363 | Primate cell, per se |
| | 364 | Monkey kidney |
| | 366 | Human |
| | 373 | Method of co-culturing cells |
| | 374 | Method of storing cells in a viable state |
| | 375 | Method of regulating cell metabolism or physiology |
| | 376 | Method of synchronizing cell division |
| | 377 | Method of altering the differentiation state of the cell |
| | 378 | Method of detaching cells, digesting tissue or establishing a primary culture |
| | 379 | Using mechanical means (e.g., trituration, etc.) |
| | 380 | Releasing bound or adhered cell using protease |
| | 381 | Digesting tissue with protease |
| | 382 | Method of culturing encapsulated cells |
| | 383 | Method of culturing cells in suspension |
| | 384 | Culture medium contains a growth factor or growth regulator |
| | 385 | Medium contains a colony stimulating factor |
| | 386 | Medium contains an interleukin |
| | 387 | Medium contains a polypeptide hormone |
| | 388 | Culture medium contains an albumin |
| | 389 | Culture medium contains a transferrin |
| | 390 | Culture medium contains an incompletely defined plant or microbial extract excluding animal extract |
| | 391 | Culture medium contains an animal extract |
| | 393 | Using airlift or laminar flow aeration or foam culture |
| | 394 | Wherein culture vessel is rotated or oscillated or culture is agitated |
| | 395 | Solid support and method of culturing cells on said solid support |
| | 396 | Support is a resin |
| | 397 | Support is a gel surface |
| | 398 | Support is a fiber |
| | 401 | Support is a membrane |
| | 402 | Support is a coated or treated surface |
| | 403 | Support is a suspendable particle |
| | 404 | Culture medium, per se |
| | 410 | PLANT CELL OR CELL LINE, PER SE (E.G., TRANSGENIC, MUTANT, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING, OR PRESERVING PLANT CELL OR CELL LINE; PROCESS OF ISOLATING OR SEPARATING A PLANT CELL OR CELL LINE; PROCESS OF REGENERATING PLANT CELLS INTO TISSUE, PLANT PART, OR PLANT, PER SE, WHERE NO GENOTYPIC CHANGE OCCURS; MEDIUM THEREFORE |
| | 411 | Tomato cell or cell line, per se |
| | 412 | Corn cell or cell line, per se |
| | 414 | Tobacco cell or cell line, per se |
| | 415 | Soybean cell or cell line, per se |
| | 416 | Sunflower cell or cell line, per se |
| | 417 | Potato cell or cell line, per se |
| | 418 | Plant cell or cell line, per se, is pest or herbicide resistant or pest lethal |
| | 419 | Plant cell or cell line, per se, contains exogenous or foreign nucleic acid |
| | 420 | Culture, maintenance, or preservation techniques, per se |
| | 421 | Involving protoplast |
| | 422 | Involving conifer cell or tissue (e.g., pine, spruce, fir, cedar, etc.) |
| | 423 | Involving tomato cell or tissue |
| | 424 | Involving corn cell or tissue |
| | 425 | Involving tobacco cell or tissue |
| | 426 | Involving soybean cell or tissue |
| | 427 | Involving cotton cell or tissue |
| | 428 | Involving sunflower cell or tissue |
| | 429 | Involving potato cell or tissue |
| | 430 | Involving regeneration or propagation into a plant or plant part |
| | 431 | Medium, per se, for culture, maintenance, regeneration, etc. |
| | 242 | SPORE FORMING OR ISOLATING PROCESS |
| | 243 | MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR |
| | 244 | Chemical stimulation of growth or activity by addition of chemical compound which is not an essential growth factor; stimulation of growth by removal of a chemical compound |
| | 245 | Adaptation or attenuation of cells |
| | 246 | Foam culture |
| | 247 | Utilizing media containing lower alkanol (i.e., having one to six carbon atoms) |
| | 248 | Utilizing media containing hydrocarbon |
| | 251 | Utilizing media containing waste sulphite liquor |
| | 252 | Utilizing media containing cellulose or hydrolysates thereof |
| | 252.1 | Bacteria or actinomycetales; media therefor |
| | 252.2 | Rhizobium or agrobacterium |
| | 252.3 | Transformants (e.g., recombinant DNA or vector or foreign or exogenous gene containing, fused bacteria, etc.) |
| | 252.31 | Bacillus (e.g., B. subtilis, B. thuringiensis, etc.) |
| | 252.32 | Brevibacterium or corynebacterium |
| | 252.33 | Escherichia (e.g., E. coli, etc.) |
| | 252.34 | Pseudomonas |
| | 252.35 | Streptomyces |
| | 252.4 | Mixed culture |
| | 252.5 | Bacillus (e.g., B. subtilis, B. thuringiensis, etc.) |
| | 252.6 | Actinoplanes |
| | 252.7 | Clostridium |
| | 252.8 | Escherichia (e.g., E. coli, etc.) or salmonella |
| | 252.9 | Lactobacillus, pediococcus, or leuconostoc |
| | 253.1 | Mycobacterium |
| | 253.2 | Nocardia |
| | 253.3 | Pseudomonas |
| | 253.4 | Streptococcus |
| | 253.5 | Streptomyces |
| | 253.6 | Culture media, per se |
| | 254.1 | Fungi |
| | 254.11 | Transformants |
| | 254.2 | Yeast; media therefor |
| | 254.3 | Aspergillus |
| | 254.4 | Neurospora |
| | 254.5 | Penicillium |
| | 254.6 | Trichoderma |
| | 254.7 | Fusarium |
| | 254.8 | Mucor |
| | 254.9 | Rhizopus |
| | 255.1 | Yeast |
| | 255.2 | Saccharomyces |
| | 255.3 | Cryptococcus |
| | 255.4 | Candida or torulopsis |
| | 255.5 | Pichia |
| | 255.6 | Hansenula |
| | 255.7 | Culture media, per se, or technique |
| | 256.1 | Aspergillus |
| | 256.2 | Mucor |
| | 256.3 | Penicillium |
| | 256.4 | Cephalosporium or acremonium |
| | 256.5 | Fusarium |
| | 256.6 | Rhizopus |
| | 256.7 | Trichoderma |
| | 256.8 | Culture media, per se, or technique |
| | 257.1 | Algae, media therefor |
| | 258.1 | Protozoa, media therefor |
| | 259 | Lysis of micro-organism |
| | 260 | Preserving or maintaining micro-organism |
| | 261 | Separation of micro-organism from culture media |
| | 320.1 | VECTOR, PER SE (E.G., PLASMID, HYBRID PLASMID, COSMID, VIRAL VECTOR, BACTERIOPHAGE VECTOR, ETC.) BACTERIOPHAGE VECTOR, ETC.) |
| | 262 | PROCESS OF UTILIZING AN ENZYME OR MICRO-ORGANISM TO DESTROY HAZARDOUS OR TOXIC WASTE, LIBERATE, SEPARATE, OR PURIFY A PREEXISTING COMPOUND OR COMPOSITION THEREFORE; CLEANING OBJECTS OR TEXTILES |
| | 262.5 | Destruction of hazardous or toxic waste |
| | 263 | Textile treating |
| | 264 | Cleaning using a micro-organism or enzyme |
| | 265 | Depilating hides, bating, or hide treating using enzyme or micro-organism |
| | 266 | Treating gas, emulsion, or foam |
| | 267 | Treating animal or plant material or micro-organism |
| | 268 | Treating organ or animal secretion |
| | 269 | Treating blood fraction |
| | 270 | Removing nucleic acid from intact or disrupted cell |
| | 271 | Glyceridic oil, fat, ester-type wax, or higher fatty acid recovered or purified |
| | 272 | Proteinaceous material recovered or purified |
| | 274 | Carbohydrate material recovered or purified |
| | 280 | Resolution of optical isomers or purification of organic compounds or composition containing same |
| | 281 | Petroleum oil or shale oil treating |
| | 283.1 | APPARATUS |
| | 284.1 | Differentiated tissue (e.g., organ) perfusion or preservation apparatus |
| | 285.1 | Mutation or genetic engineering apparatus |
| | 285.2 | With means for applying an electric current or charge (e.g., electrofusion, electroporation, etc.) |
| | 285.3 | Including projectile means |
| | 286.1 | Including condition or time responsive control means |
| | 286.2 | Including position control |
| | 286.5 | Including liquid flow, level, or volume control |
| | 286.6 | Including gas flow or pressure control |
| | 286.7 | Including mixing or agitation control |
| | 287.1 | Including measuring or testing |
| | 287.2 | Measuring or testing for antibody or nucleic acid, or measuring or testing using antibody or nucleic acid |
| | 287.3 | With sample or reagent mechanical transport means |
| | 287.4 | Sterility testing means |
| | 287.5 | Means for measuring gas pressure or gas volume of gas evolved from or consumed in an enzymatic or microbial reaction |
| | 287.6 | Including frangible means for introducing a sample or reagent |
| | 287.7 | Including bibulous or absorbent layer |
| | 287.9 | Including a coated reagent or sample layer |
| | 288.1 | Including a bottle, tube, flask, or jar |
| | 288.3 | Including a dish, plate, slide, or tray |
| | 288.6 | Including column separation means |
| | 288.7 | Including optical measuring or testing means |
| | 289.1 | Bioreactor |
| | 290.1 | Composting apparatus |
| | 290.2 | Including agitation means |
| | 290.4 | Including solid or liquid transport means into or out of a compostor |
| | 291.1 | Malting or mashing apparatus |
| | 291.2 | Movable floor to facilitate maintenance (e.g., cleaning) |
| | 291.3 | Vertically spaced stages, levels, or floors |
| | 291.5 | With agitator or mash turner |
| | 292.1 | Including means to transmit light into a bioreactor to facilitate photo- bioreaction (e.g., photosynthesis) |
| | 293.1 | Tubular or plug flow bioreactor |
| | 294.1 | Vessels or trays in series |
| | 295.1 | Including a draft tube for agitation |
| | 296.1 | Bubble bioreactor |
| | 297.1 | Including semipermeable membrane or filter |
| | 297.2 | Including perfusion means |
| | 297.3 | Including a spinning semipermeable membrane or filter |
| | 297.4 | Including hollow fiber or capillary |
| | 297.5 | In combination with a dish, plate, or tray |
| | 298.1 | Cylindrical reaction tank or vessel horizontally disposed with respect to its central axis |
| | 299.1 | Including solid extended fluid contact reaction surface |
| | 300.1 | Including off-gas trapping means |
| | 301.1 | Including foam breaking means |
| | 302.1 | Including magnetically coupled agitation means |
| | 303.1 | Incubator |
| | 303.2 | Specifically adapted for an anaerobic microorganism or enzyme (e.g., anaerobe jars) |
| | 303.3 | Including an agitator |
| | 304.1 | Bottle, tube, jar, or flask |
| | 305.1 | Dish, plate, or tray |
| | 306.1 | Involving lysis of a microorganism by means other than comminution |
| | 307.1 | Microorganism preservation, storage, or transport apparatus |
| | 308.1 | Means for separation or recovery of a microorganism from culture media |
| | 309.1 | Inoculator, streaker, or sampler |
| | 317.1 | MISCELLANEOUS (E.G., SUBCELLULAR PARTS OF MICRO-ORGANISMS, ETC.) |
| CROSS-REFERENCE ART COLLECTIONS | ||
| | 800 | ELIMINATION OR REDUCTION OF CONTAMINATION BY UNDERSIRED FERMENTS (E.G., ASEPTIC CULTIVATION) |
| | 801 | ANEROBIC CULTIVATION |
| | 802 | LOGARITHMIC GROWTH PHASE |
| | 803 | PHYSICAL RECOVERY METHODS (E.G., CHROMATOGRAPHY, GRINDING) |
| | 804 | SINGLE CELL PROTEIN |
| | 805 | TEST PAPERS |
| | 806 | FERTILITY TESTS |
| | 807 | GAS DETECTION APPARATUS |
| | 808 | OPTICAL SENSING APPARATUS |
| | 809 | INCUBATORS OR RACKS OR HOLDERS FOR CULTURE PLATES OR CONTAINERS |
| | 810 | PACKAGED DEVICE OR KIT |
| | 811 | INTERFERON |
| | 812 | FOAM CONTROL |
| | 813 | CONTINUOUS FERMENTATION |
| | 814 | ENZYME SEPARATION OR PURIFICATION |
| | 817 | ENZYME OR MICROBE ELECTRODE |
| | 818 | AERATION OR OXYGEN TRANSFER TECHNIQUE |
| | 819 | FERMENTATION VESSELS IN SERIES |
| | 820 | SUBCELLULAR PARTS OF MICRO-ORGANISMS |
| | 821 | MICRO-ORGANISMS USED IN THE DESTRUCTION OF HAZARDOUS OR TOXIC WASTE |
| MICRO-ORGANISM CROSS-REFERENCE ART COLLECTIONS |
| | 822 | Using bacteria or actinomycetales |
| | 823 | Acetobacter |
| | 824 | Achromobacter |
| | 825 | Actinomadura |
| | 826 | Actinomyces |
| | 827 | Actinoplanes |
| | 828 | Aerobacter |
| | 829 | Alcaligenes |
| | 830 | Arthrobacter |
| | 831 | Azotobacter |
| | 832 | Bacillus |
| | 833 | Bacillus brevis |
| | 834 | Bacillus cereus |
| | 835 | Bacillus circulans |
| | 836 | Bacillus licheniformis |
| | 837 | Bacillus megaterium |
| | 838 | Bacillus polymyxa |
| | 839 | Bacillus subtilis |
| | 840 | Brevibacterium |
| | 841 | Chainia |
| | 842 | Clostridium |
| | 843 | Corynebacterium |
| | 847 | Erwinia |
| | 848 | Escherichia |
| | 850 | Flavobacterium |
| | 851 | Haemophilus |
| | 852 | Klebsiella |
| | 853 | Lactobacillus |
| | 854 | Lactobacillus acidophilus |
| | 855 | Lactobacillus brevis |
| | 856 | Lactobacillus casei |
| | 857 | Lactobacillus plantarum |
| | 858 | Methylomonas |
| | 859 | Micrococcus |
| | 863 | Mycobacterium |
| | 867 | Micromonospora |
| | 870 | Mycoplasma |
| | 871 | Neisseria |
| | 872 | Nocardia |
| | 873 | Proteus |
| | 874 | Pseudomonas |
| | 878 | Rhizobium |
| | 879 | Salmonella |
| | 880 | Serratia |
| | 882 | Staphylococcus |
| | 885 | Streptococcus |
| | 886 | Streptomyces |
| | 887 | Streptomyces albus |
| | 888 | Streptomyces antibioticus |
| | 889 | Streptomyces aureofaciens |
| | 890 | Streptomyces aureus |
| | 891 | Streptomyces bikiniensia |
| | 892 | Streptomyces candidus |
| | 893 | Streptomyces chartreusis |
| | 894 | Streptomyces diastatochromogenes |
| | 895 | Streptomyces filipinensis |
| | 896 | Streptomyces fradiae |
| | 897 | Streptomyces griseus |
| | 898 | Streptomyces hygroscopicus |
| | 899 | Streptomyces lavendulae |
| | 900 | Streptomyces lincolnensis |
| | 901 | Streptomyces noursei |
| | 902 | Streptomyces olivaceus |
| | 903 | Streptomyces platensis |
| | 904 | Streptomyces rimosus |
| | 905 | Streptomyces sparogenes |
| | 906 | Streptomyces venezuelae |
| | 907 | Streptosporangium |
| | 908 | Streptovirticillium |
| | 909 | Vibrio |
| | 910 | Xanthomonas |
| | 911 | Using fungi |
| | 912 | Absidia |
| | 913 | Aspergillus |
| | 914 | Aspergillus awamori |
| | 915 | Aspergillus flavus |
| | 916 | Aspergillus fumigatus |
| | 917 | Aspergillus niger |
| | 918 | Aspergillus oryzae |
| | 919 | Aspergillus ustus |
| | 920 | Aspergillus wenti |
| | 921 | Candida |
| | 925 | Cephalosporium |
| | 929 | Fusarium |
| | 930 | Hansenula |
| | 931 | Mucor |
| | 932 | Paecilomyces |
| | 933 | Penicillium |
| | 938 | Pichia |
| | 939 | Rhizopus |
| | 940 | Saccharomyces |
| | 944 | Torulopsis |
| | 945 | Trichoderma |
| | 946 | Using algae |
| | 947 | Using protozoa |
| | 948 | Using viruses or cell lines |
| CROSS-REFERENCE ART COLLECTIONS | ||
| RELATED TO SUBCLASSES |
| 7.1 THROUGH 7.95 |
| | 960 | IMMUNOHISTOCHEMICAL ASSAY |
| | 961 | INCLUDING A STEP OF FORMING, RELEASING, OR EXPOSING THE ANTIGEN OR FORMING THE HAPTEN-IMMUNOGENIC CARRIER COMPLEX OR THE ANTIGEN, PER SE |
| | 962 | PREVENTION OR REMOVAL OF INTERFERING MATERIALS OR REACTANTS OR OTHER TREATMENT TO ENHANCE RESULTS (E.G., DETERMINING OR PREVENTING NONSPECIFIC BINDING, ETC.) |
| | 963 | METHODS OF STOPPING AN ENZYME REACTION OR STABILIZING THE TEST MATERIALS |
| | 964 | INCLUDING ENZYME-LIGAND CONJUGATE PRODUCTION (E.G., REDUCING RATE OF NONPRODUCTIVE LINKAGE, ETC.) |
| | 965 | INVOLVING IDIOTYPE OR ANTI-IDIOTYPE ANTIBODY |
| | 966 | INVOLVING AN ENZYME SYSTEM WITH HIGH TURNOVER RATE OR COMPLEMENT MAGNIFIED ASSAY (E.G., MULTI-ENZYME SYSTEMS, ETC.) |
| | 967 | STANDARDS, CONTROLS, MATERIALS (E.G., VALIDATION STUDIES, BUFFER SYSTEMS, ETC.) |
| | 968 | HIGH ENERGY SUBSTRATES (E.G., FLUORESCENT, CHEMILUMINESCENT, RADIOACTIVE, ETC.) |
| | 969 | MULTIPLE LAYERING OF REACTANTS |
| | 970 | TEST STRIP OR TEST SLIDE |
| | 971 | CAPTURE OF COMPLEX AFTER ANTIGEN-ANTIBODY REACTION |
| | 972 | MODIFIED ANTIBODY (E.G., HYBRID, BIFUNCTIONAL, ETC.) |
| | 973 | SIMULTANEOUS DETERMINATION OF MORE THAN ONE ANALYTE |
| | 974 | AIDS RELATED TEST |
| | 975 | KIT |
| FOREIGN ART COLLECTIONS | ||
| FOR000 | CLASS-RELATED FOREIGN DOCUMENTS |
| Any foreign patents or non-patent literature from subclasses that have been reclassified have been transferred directly to FOR Collections listed below. These Collections contain ONLY foreign patents or non-patent literature. The parenthetical references in the Collection titles refer to the abolished subclasses from which these Collections were derived. | ||
| FOR100 | ANIMAL OR PLANT CELL (E.G., CELL LINES, ETC.); COMPOSITIONS THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING ANIMAL OR PLANT CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL OR PLANT CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING ANIMAL OR PLANT CELL; CULTURE MEDIA THEREFORE (435/240.1) |
| FOR101 | Animal cells, per se, culture techniques and media (435/240.2) |
| FOR102 | Techniques of establishing a primary culture (435/240.21) |
| FOR103 | Culture of encapsulated cells (435/240.22) |
| FOR104 | Culture of cells on solid support (e.g., anchorage dependent cells) (435/240.23) |
| FOR105 | Support is suspendable particle (435.240.24) |
| FOR106 | Culture of cells on membrane (435/240.241) |
| FOR108 | Solid support treated or coated to enhance attachment or growth (435/240.243) |
| FOR109 | Culture in suspension (435/240.25) |
| FOR110 | Fused or hybrid cells (435/240.26) |
| FOR112 | Culture medium, per se (435/240.3) |
| FOR114 | Plant cells, per se, culture techniques and media (435/240.4) |
| FOR123 | MUTATION OR GENETIC ENGINEERING (435/172.1) |
| FOR126 | OBTAINING THE DESIRED GENE; DNA, RNA PER SE AND THE MODIFICATION THEREOF OTHER THAN VECTOR MODIFICATION (935/1) |
| FOR127 | DNA-RNA hybrid (935/2) |
| FOR128 | RNA (935/3) |
| FOR131 | DNA, e.g., regulatory sequences, etc. (935/6) |
| FOR132 | Homopolymeric, e.g., poly d(A) sequence, etc. (935/7) |
| FOR133 | 12-75 nucleotides in length, e.g., primers, etc. (935/8) |
| FOR134 | Structural gene sequence (935/9) |
| FOR141 | Methods of producing DNA or RNA other than by expression vectors, e.g., culture of cells high in DNA, etc. (935/16) |
| FOR144 | Isolation or purification of DNA or RNA (935/19) |
| FOR147 | VECTORS AND METHODS OF MODIFYING VECTORS (935/22) |
| FOR158 | METHODS OF ENHANCING OR DIMINISHING EXPRESSION (935/33) |
| FOR159 | Eukaryotic cell (935/34) |
| FOR163 | Prokaryotic cell (935/38) |
| FOR164 | Transcription (935/39) |
| FOR167 | Gene dosage modification, e.g., copy number amplification, etc. (935/42) |
| FOR169 | Translation (935/44) |
| FOR172 | Fused protein or peptide (435/47) |
| FOR174 | Post translational modification (935/49) |
| FOR177 | METHODS OF INTRODUCING GENE INTO HOST CELL, E.G., TRANSFORMATION OR TRANSFECTION, ETC. (935/52) |
| FOR178 | Microinjection (935/53) |
| FOR179 | Microencapsulation, e.g., liposome vesicle, etc. (935/54) |
| FOR180 | Using vector, e.g., plasmid, etc. (935/55) |
| FOR184 | METHOD OF USE OF GENETICALLY ENGINEERED CELLS, E.G., OIL SPILL CLEANUP, ETC. (935/59) |
| FOR185 | To produce an identified chemical product, e.g., amino acid, etc. (935/60) |
| FOR187 | Control of genetic diseases or defects by use of added gene, e.g., gene therapy (935/62) |
| FOR188 | Use in animal husbandry (935/63) |
| FOR189 | Use in agriculture (935/64) |
| FOR190 | Vaccine production (935/65) |
| FOR191 | CELLS CONTAINING A VECTOR AND/OR EXOGENOUS GENE, PER SE; PROPAGATION THEREOF; OTHER MEMBRANE ENCAPSULATED DNA, E.G., PROTOPLASTS, ETC. (935/66) |
| FOR192 | Plant cells (935/67) |
| FOR193 | Fungal cells (935/68) |
| FOR195 | Animal cell (935/70) |
| FOR197 | Bacteria (935/72) |
| FOR201 | ASSAY RELATED TO GENETIC ENGINEERING (935/76) |
| FOR202 | Methods of analysis of nucleic acids (935/77) |
| FOR204 | Methods of selection of recombinant gene containing vector; materials therefore, e.g., replica plating, etc. (935/79) |
| FOR210 | GENETIC ENGINEERING APPARATUS (935/85) |
| FOR211 | Analytical, e.g., for autoradiography, etc. (935/86) |
| FOR213 | Synthesis, e.g., peptide or gene synthesizers, etc. (935/88) |
| FOR214 | HYBRID OR FUSED CELL TECHNOLOGY, METHODS OF IMMORTALIZING CELLS, E.G., HYBRIDOMA, ETC. (935/89) |
| FOR215 | Method of selection of the desired cell (935/90) |
| FOR216 | Of plant cells, e.g., protoplasts, etc. (935/91) |
| FOR217 | Using positive selection technique (935/92) |
| FOR218 | Method of production of hybrid or fused cells, e.g., chromosome or genome transfer techniques, etc. (935/93) |
| FOR220 | Fused or hybrid cell, per se (935/95) |
| FOR221 | Interspecies fusion (935/96) |
| FOR222 | Fungi, e.g., yeasts, etc. (935/97) |
| FOR223 | Plant cells (935/98) |
| FOR224 | Human cell 935/99) |
| FOR227 | Animal cell (935/102) |
| FOR231 | Method of use of the fused or hybrid cell or the product thereof (935/106) |
| FOR236 | MISCELLANEOUS (935/111) |
| DIGESTS | ||
This page is produced by the Office of Classification Support (Office of Patent Classification) for the Reference Tools Project.
Please send questions and comments to usptoinfo@uspto.gov .
Note: The Patent and Trademark Depository Library Program (PTDLP) administers a nationwide network of public, state and academic libraries designated as Patent and Trademark Depository Libraries authorized by 35 U.S.C. 13 to: Disseminate Patent and Trademark Information Support Diverse Intellectual Property Needs of the Public. PTDL Contact Information
Note: For information/comments on electronic information products, such as purchasing USPTO data, or to discuss system requirements for magnetic tape products, contact:
Information Products Division -- U.S. Patent and Trademark Office
Information Products Division
Contact Information
Or, browse
their on-line catalog.
The Inventors Assistance Center is available to help you on patent matters.Send questions about USPTO programs and services to the USPTO Contact Center (UCC). You can suggest USPTO webpages or material you would like featured on this section by E-mail to the webmaster@uspto.gov. While we cannot promise to accommodate all requests, your suggestions will be considered and may lead to other improvements on the website. |
|
|
=online
business system 
=fees 
=forms
=help 
=laws/regulations 
=definition
(glossary)